Expanding Treatment Options for HER2+ Breast Cancer
June 30, 2020
Adam Brufsky, MD, PhD, UPMC Hillman Cancer CenterAdam Brufsky, MD, PhD, UPMC Hillman Cancer Center
, Carey K. Anders, MD, Duke Cancer InstituteCarey K. Anders, MD, Duke Cancer Institute
, Virginia Kaklamani, MD, University of Texas Health Science CenterVirginia Kaklamani, MD, University of Texas Health Science Center
, Rashmi K. Murthy, MD, MBE, MD Anderson Cancer CenterRashmi K. Murthy, MD, MBE, MD Anderson Cancer Center
, Mark D. Pegram, MD, Stanford Cancer CenterMark D. Pegram, MD, Stanford Cancer Center